Gyre Therapeutics Inc.
GYRE | NASDAQ
$4.74
+$0.19 (+4.06%)
Nov 2, 2026, 11:25 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -28.15M | -3.58M | 8.84M | 11.82M | 7M | 8.96M | 15.16M | -86.39M | -80M | -79.76M | -87.45M | -26.93M | -39.32M | 8.54M | 14.23M | 34.35M | 14M | -57.56M | -87.93M | -86.51M | -77.31M | -74.63M |
Depreciation & Amortization | 3.46M | 2.62M | 2.48M | 2.3M | 2.1M | 1.7M | 1.58M | 1.42M | 1.16M | 1.24M | 1.11M | 816K | 654K | 403K | 606.17K | 711.17K | 756.17K | 734.17K | 290K | 220K | 177K | 158K |
Stock-Based Compensation | 7.82M | 6.65M | 7.16M | 3.13M | 1.98M | 1.07M | 578K | 7.29M | 7.29M | 7.29M | 7.28M | n/a | n/a | n/a | 640.96K | 640.96K | 1.35M | 2.34M | 2.72M | 2.72M | 3.08M | 2.93M |
Other Working Capital | 5.67M | 3.27M | 17K | 328K | 1.36M | -5.29M | -4.02M | -3.84M | -3.65M | 790K | 4.22M | 5.56M | 4.38M | -724K | -1.11M | -4.79M | -3.07M | 1.79M | -1.51M | -5.61M | -6.83M | -6M |
Other Non-Cash Items | 2.08M | 2.06M | -1.73M | -2.04M | 57K | -1.39M | -4.43M | 91.4M | 90.07M | 91.98M | 98.65M | 86.14M | 85.79M | 28.87M | 25.7M | -56.79M | -57.12M | -221.26K | 683K | 920K | 920K | 920K |
Deferred Income Tax | -1.86M | -738K | -191K | -1.61M | -1.08M | -880K | -1M | -813K | -1.01M | -1.15M | -1.16M | -1.6M | -1.4M | -1.17M | -838K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.16M | -2.69M | -15.55M | -9.71M | -9.18M | -16.28M | -15.69M | -10.6M | -9.3M | -1.25M | 7.46M | 6.4M | 4.25M | -3.5M | -8.62M | -7.17M | -1.56M | 4.31M | 483K | -5.54M | -6.47M | -3.99M |
Operating Cash Flow | -14.5M | 4.32M | 1.01M | 3.88M | 877K | -6.82M | -3.81M | 2.31M | 8.21M | 18.36M | 25.89M | 64.83M | 49.97M | 33.14M | 31.72M | -28.25M | -42.57M | -50.4M | -83.76M | -88.19M | -79.6M | -74.61M |
Capital Expenditures | -2.29M | -1.28M | -1.93M | -2.53M | -2.54M | -3.72M | -3.13M | -4.71M | -5.99M | -7.01M | -8.52M | -8.61M | -6.63M | -6.73M | -8.11M | -5.7M | -6.19M | -3.96M | -839K | -878K | -581K | -250K |
Cash Acquisitions | 6K | 6K | n/a | n/a | -5K | 213K | 213K | 5.23M | 5.24M | 5.02M | 5.02M | -55.45M | -55.45M | n/a | n/a | 55.45M | 55.45M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -20.69M | -18.51M | -13.97M | -13.15M | -14.27M | -25.56M | -24.2M | -24.2M | -25.3M | -16.93M | -9.89M | -9.83M | -7.04M | -1.33M | -1.33M | n/a | n/a | n/a | n/a | -5.89M | -50.55M | -91.62M |
Sales Maturities Of Investments | 30.3M | 14.31M | 15.43M | 11.19M | 11.19M | 11.19M | n/a | n/a | n/a | n/a | n/a | -2.5M | -2.5M | -2.5M | -2.5M | 2.87M | 10.4M | 21.45M | 49.03M | 79.64M | 95.7M | 101.69M |
Other Investing Acitivies | -1.06M | -50K | -748K | -1.39M | -1.38M | 5.67M | 6.42M | 7.13M | 6.49M | -414K | -6.31M | -13.83M | -13.19M | -13.33M | -10.02M | -2.54M | -2.54M | -2.54M | n/a | n/a | n/a | n/a |
Investing Cash Flow | 7.3M | -5.5M | -474K | -4.33M | -5.47M | -10.7M | -19.88M | -16.54M | -19.55M | -19.33M | -19.76M | -90.29M | -84.89M | -23.97M | -19.44M | 52.61M | 59.65M | 17.49M | 48.19M | 72.87M | 44.57M | 9.82M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -114.19K | -114.19K | -114.19K | -114.19K | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 45.03M | n/a | n/a | n/a | -45.03M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 157K | -284K | 551K | 1.52M | 1.15M | 1.8M | 1.62M | 3.16M | 3.16M | 3.16M | 2.5M | n/a | n/a | n/a | -13.68K | -13.68K | -13.68K | -13.68K | n/a | n/a | n/a | n/a |
Financial Cash Flow | 696K | 23.06M | 24.38M | 25.02M | 25.03M | 2.96M | 2.27M | 3.81M | 3.43M | 3.16M | 2.5M | 45.01M | -16K | -137.56K | -265.44K | -45.28M | -151.44K | -33.88K | 49.55M | 49.55M | 49.38M | 77.47M |
Net Cash Flow | 6.8M | 22.46M | 25.26M | 24.54M | 20.39M | -14.74M | -21.7M | -10.21M | -7.63M | 1.64M | -8.2M | -13.55M | -68.2M | -23.21M | -3.9M | -20.79M | 17.05M | -32.95M | 13.99M | 34.23M | 14.35M | 12.68M |
Free Cash Flow | -16.79M | 3.04M | -917K | 1.35M | -1.66M | -10.54M | -6.94M | -2.4M | 2.23M | 11.35M | 17.37M | 56.23M | 43.34M | 26.42M | 23.62M | -33.95M | -48.76M | -54.36M | -84.59M | -89.07M | -80.18M | -74.86M |
Adj. Free Cash Flow | -24.61M | -3.62M | -8.07M | -1.78M | -3.64M | -11.61M | -7.51M | -9.69M | -5.07M | 4.06M | 10.09M | 56.23M | 43.34M | 26.42M | 22.97M | -34.59M | -50.12M | -56.7M | -87.32M | -91.79M | -83.26M | -77.79M |
Maintenance CapEx | -1.46M | -178K | -821K | -1.41M | -2.1M | -3.56M | -2.74M | -4.47M | -5.16M | -3.7M | -3.7M | -1.38M | n/a | -2.58M | -5.7M | -5.7M | -5.74M | -3.51M | -391.44K | -391.44K | -347K | n/a |
Growth CapEx | -827K | -1.11M | -1.11M | -1.12M | -437.23K | -158.23K | -389.23K | -231K | -829K | -3.31M | -4.82M | -7.23M | -6.63M | -4.15M | -2.41M | n/a | -447.56K | -447.56K | -447.56K | -486.56K | -234K | -250K |
Owner Earnings | -15.96M | 4.14M | 189K | 2.47M | -1.22M | -10.38M | -6.55M | -2.17M | 3.06M | 14.66M | 22.19M | 63.45M | 49.97M | 30.57M | 26.02M | -33.95M | -48.32M | -53.92M | -84.15M | -88.58M | -79.95M | -74.61M |
Add to Watchlist
Select watchlists to add or remove GYRE